Parsing Negative Citations

A new tool helps scientists better understand what happens to studies that are criticized in the literature.

Written byKelly Rae Chi
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

PIXABAY, OPENCLIPARTVECTORSDuring the course of their careers, many scientists criticize the work of others—pointing out flaws, inconsistencies, or contradictions—in the literature. This is part of scientific progress. A proof-of-concept study now describes a research tool for recognizing these so-called negative citations, making it possible to contextualize and study them on a larger scale than possible before.

According to the results, published today (October 26) in PNAS, papers pay only a slight long-term penalty in the total number of citations they receive after a negative one. That criticized papers continue to garner citations over time suggests that it’s better to receive negative attention than none at all.

Until now, the best way of studying negative citations was by reading and coding each individual article—something Jeffrey Furman, an associate professor of strategy and innovation at Boston University, said he tried before, while analyzing the impact of retracted studies. In contrast, the new method, which employs natural language processing and machine learning, “could have saved me dozens of hours, if only I had waited,” said Furman, who was not involved with the study. “Coming ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies